My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

383.34 -5.45 (-1.40%)
Official Closing Price Updated: 7:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Stryker Corp

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
These three top-notch stocks would make great additions to any dividend portfolio. 
Via The Motley Fool
Why Stryker Stock Rose Today
Stryker Corporation (NYSE: SYK) shares traded higher on Monday. 
Via Benzinga
What's Going On With Stryker Stock?
Stryker Corp (NYSE: SYK) shares are trading lower by 1.4% to $256.46 Thursday morning. 
Via Benzinga
Why Stryker (SYK) Stock Fell 5% Wednesday
Stryker Corp (NYSE: SYK) shares fell 5.26% to $260.05 Wednesday. The stock experienced weakness after the FDA established a Digital Health Advisory Committee. 
Via Benzinga
How Is The Market Feeling About Stryker?
 
Via Benzinga
Here's How Much You Would Have Made Owning Stryker Stock In The Last 20 Years
 
Via Benzinga
Looking At Stryker's Recent Unusual Options Activity
 
Via Benzinga
Peering Into Stryker's Recent Short Interest
 
Via Benzinga
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
 
Via Benzinga
Looking Into Stryker's Recent Short Interest
 
Via Benzinga
Three Of Our Top Picks For Your Healthcare Portfolio
Amidst macro uncertainty, healthcare stocks should outperform. 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,500 Today
 
Via Benzinga
$1000 Invested In Stryker 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Is This MedTech Giant a Buy for Dividend Investors?
The company stands out as a titan of the medical devices industry. 
Via The Motley Fool
Stryker Bull Expects Upside For Medtech Stock In '24, Ortho To Be 'Higher For Longer'
Shares of Stryker Corp (NYSE: SYK) continued to rise in early trading on Tuesday, after ending last week with gains. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
 
Via Benzinga
Where Stryker Stands With Analysts
 
Via Benzinga
Peering Into Stryker's Recent Short Interest
 
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
A Preview Of Stryker's Earnings
 
Via Benzinga
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months. 
Via Talk Markets
Topics ETFs
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year. 
Via Investor's Business Daily
Stryker, NextEra Energy And A Stock Down 18% In Past Month: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Josh Brown of Ritholtz Wealth Management said he is sticking with NextEra Energy, Inc. (NYSE: NEE) 
Via Benzinga
Stryker, Wynn Resorts And A Chinese Tech Giant Expanding AI Capabilities: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named Alibaba Group Holding Limited (NYSE: BABA) as his 
Via Benzinga
Nikola's Abrupt CEO Transition, Carl Icahn Led Icahn Enterprises Cuts Dividend Payout, FDA Rejects Mesoblast's Cell Therapy For Kids: Today's Top Stories
Wall Street Journal 
Via Benzinga
Looking At Stryker's Recent Unusual Options Activity
 
Via Benzinga
Stryker Stock Gets A Boost From Annual Guidance Hike On Better Than Expected Q2 Earnings: The Details
Stryker Corporation (NYSE: SYK) reported Q2 sales of $5 billion, up 11.2% Y/Y (+11.9% in constant currency), beating the consen 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.